4-(((4-(4-氯苯氧基)苯基)磺酰基)甲基)-N-羟基四氢-2H-吡喃-4-甲酰胺 4-(((4-(4-氯苯氧基)苯基)磺酰基)甲基)-N-羟基四氢-2H-吡喃-4-甲酰胺

CAS 193022-04-7 MFCD93022047

化学结构图

193022-04-7
SMILES:

别名和识别编码

Chemical Name Translation4-(((4-(4-氯苯氧基)苯基)磺酰基)甲基)-N-羟基四氢-2H-吡喃-4-甲酰胺
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Johnson JL, et al. Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability. Cardiovasc Res. 2006 Aug 1;71(3):586-595.
  • [1]. Kahraman A, et al. Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse. Hepatol Res. 2009 Aug;39(8):805-813.
  • [1]. Kahraman A, et al. Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse. Hepatol Res. 2009 Aug;39(8):805-813.
  • [2]. Johnson JL, et al. Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability. Cardiovasc Res. 2006 Aug 1;71(3):586-595.

系列性分类

  1. Medical Research Areas
  2. Metabolism
  3. MMP  (基质金属蛋白酶)

相关产品推荐